Showing 15,921 - 15,940 results of 35,226 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 5 ((point decrease) OR (nn decrease)) ))', query time: 1.05s Refine Results
  1. 15921

    Table_1_Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma.xlsx by Erna-Elise Paulsen (781451)

    Published 2023
    “…In multivariate analyses, LUAD NAA+ pattern was a significant independent prognostic factor; HR 2.37 (CI 95%, 1.50-3.73, p< 0.001). …”
  2. 15922

    Image_1_Association of Dietary Fiber Intake With Myocardial Infarction and Stroke Events in US Adults: A Cross-Sectional Study of NHANES 2011–2018.TIF by Weiwei Dong (462016)

    Published 2022
    “…We enrolled 8,872 participants (mean dietary fiber intake, 17.38 ± 0.22 g/day). The weighted prevalence of nonfatal cardiovascular/cerebrovascular events was 5.36%, which decreased with higher dietary fiber intake (nonfatal cardiovascular/cerebrovascular events: Tertile1, 6.50%; Tertile2, 5.45%; Tertile3, 4.25%). …”
  3. 15923

    Image_2_Association of Dietary Fiber Intake With Myocardial Infarction and Stroke Events in US Adults: A Cross-Sectional Study of NHANES 2011–2018.jpg by Weiwei Dong (462016)

    Published 2022
    “…We enrolled 8,872 participants (mean dietary fiber intake, 17.38 ± 0.22 g/day). The weighted prevalence of nonfatal cardiovascular/cerebrovascular events was 5.36%, which decreased with higher dietary fiber intake (nonfatal cardiovascular/cerebrovascular events: Tertile1, 6.50%; Tertile2, 5.45%; Tertile3, 4.25%). …”
  4. 15924

    Table_1_Association of Dietary Fiber Intake With Myocardial Infarction and Stroke Events in US Adults: A Cross-Sectional Study of NHANES 2011–2018.docx by Weiwei Dong (462016)

    Published 2022
    “…We enrolled 8,872 participants (mean dietary fiber intake, 17.38 ± 0.22 g/day). The weighted prevalence of nonfatal cardiovascular/cerebrovascular events was 5.36%, which decreased with higher dietary fiber intake (nonfatal cardiovascular/cerebrovascular events: Tertile1, 6.50%; Tertile2, 5.45%; Tertile3, 4.25%). …”
  5. 15925

    Data_Sheet_1_The efficacy and safety of different endovascular modalities for infrapopliteal arteries lesions: A network meta-analysis of randomized controlled trials.docx by Julong Guo (12986249)

    Published 2022
    “…In total, 22 eligible RCTs (44 study arms; 1,348 patients) involving nine endovascular modalities or combinations [balloon angioplasty (BA), drug-coated balloon (DCB), drug-eluting stent (DES), atherectomy device + BA (AD + BA), AD + DCB, balloon-expandable bare metal stent (BMS), self-expanding stent (SES), absorbable metal stents (AMS), and inorganics-coated stent (ICS)] were included. BA had a lower 12-month primary patency rate than DCB (RR 0.50, CI 0.27, 0.93) and AD + DCB (RR 0.34, CI 0.12, 0.93). …”
  6. 15926

    Patient demographics. by Ijeoma Okoliegbe (17720566)

    Published 2024
    “…Finally, the considerable uptake of POCT by the ward consequently led to a decrease of up to 86% in the number of samples sent to the laboratory for rapid SARS-CoV-2 testing. …”
  7. 15927

    DataSheet_1_The impact of immunoglobulin G N-glycosylation level on COVID-19 outcome: evidence from a Mendelian randomization study.xlsx by Feiwu Long (12434270)

    Published 2023
    “…Two (IGP2 and IGP77) and five (IGP10, IGP14, IGP34, IGP36, and IGP50) IgG N-glycosylation traits were causally associated with a decreased risk of COVID-19 hospitalization and severity, respectively. …”
  8. 15928

    DataSheet_3_The impact of immunoglobulin G N-glycosylation level on COVID-19 outcome: evidence from a Mendelian randomization study.xlsx by Feiwu Long (12434270)

    Published 2023
    “…Two (IGP2 and IGP77) and five (IGP10, IGP14, IGP34, IGP36, and IGP50) IgG N-glycosylation traits were causally associated with a decreased risk of COVID-19 hospitalization and severity, respectively. …”
  9. 15929

    Data_Sheet_1_The Effects of a 6-Week Controlled, Hypocaloric Ketogenic Diet, With and Without Exogenous Ketone Salts, on Body Composition Responses.pdf by Alex Buga (10361168)

    Published 2021
    “…Whether augmenting ketosis with KS impacts body composition responses to a well-formulated KD remains unknown.</p><p>Purpose: To explore the effects of energy-matched, hypocaloric KD feeding (<50 g carbohydrates/day; 1.5 g/kg/day protein), with and without the inclusion of KS, on weight loss and body composition responses.…”
  10. 15930

    DataSheet_4_The impact of immunoglobulin G N-glycosylation level on COVID-19 outcome: evidence from a Mendelian randomization study.xlsx by Feiwu Long (12434270)

    Published 2023
    “…Two (IGP2 and IGP77) and five (IGP10, IGP14, IGP34, IGP36, and IGP50) IgG N-glycosylation traits were causally associated with a decreased risk of COVID-19 hospitalization and severity, respectively. …”
  11. 15931

    DataSheet_2_The impact of immunoglobulin G N-glycosylation level on COVID-19 outcome: evidence from a Mendelian randomization study.xlsx by Feiwu Long (12434270)

    Published 2023
    “…Two (IGP2 and IGP77) and five (IGP10, IGP14, IGP34, IGP36, and IGP50) IgG N-glycosylation traits were causally associated with a decreased risk of COVID-19 hospitalization and severity, respectively. …”
  12. 15932

    <i>Ssdp</i> pan-neuronal knockdown affects adult brain development. by Safa Salim (9186786)

    Published 2023
    “…Each black dot is a data point representing an independent biological replicate with 20 individual fly heads per biological replicate. …”
  13. 15933

    <i>Ssdp</i> overexpression causes abnormalities in mitochondrial morphology and dynamics. by Safa Salim (9186786)

    Published 2023
    “…(B) Mitochondrial area in SEZ (Cohen’s d = −2.0 [95 CI −2.84, −1.13], <i>p</i> < 0.0001, <i>n</i> = 10) and SLP (Cohen’s d = −3.8 [95 CI −5.39, −2.55], <i>p</i> < 0.0001, <i>n</i> = 10), and circularity in SEZ (Cohen’s d = −2.6 [95 CI −3.57, −1.65], <i>p</i> < 0.0001, <i>n</i> = 10) and SLP (Cohen’s d = −2.6 [95 CI −3.4, −1.6], <i>p</i> < 0.0001, <i>n</i> = 10) are significantly decreased, while length in SEZ (Cohen’s d = 1.5 [95 CI 0.822, 2.19], <i>p</i> = 8.0 × 10<sup>−04</sup>, <i>n</i> = 9–10) and SLP (Cohen’s d = 2.1 [95 CI 1.29, 2.86], <i>p</i> < 0.0001, <i>n</i> = 10) is significantly increased in Ssdp<sup>[2082-G4]</sup> in comparison to Elav controls. …”
  14. 15934

    Gene expression profiling, for genes involved in regulating cell cycle, in A549, MCF-7 and HepG2 cells incubated with or without etoposide under normoxic or hypoxic conditions by Jean-Philippe Cosse (37121)

    Published 2011
    “…Each value is the average of three ratio values calculated from three independent experiments ± 1 S.D. Mean ratios indicate a fold-increase or decrease in gene expression. …”
  15. 15935

    Data_Sheet_1_Cost-Utility Analysis of the Integrated Care Models for the Management of Hypertension Patients: A Quasi-Experiment in Southwest Rural China.PDF by Xiatong Ke (11080686)

    Published 2021
    “…Compared with Option 1, Option 2 yielded an additional 0.477 QALYs, and the cost decreased by $2,237.30, so the ICER was –$4,688.50/QALY, the NMB was $3,000.40, and the NHB was 1.876 QALYs. …”
  16. 15936

    Data Sheet 1_Impact of implementing a pediatric early warning system on outcomes in hematopoietic stem cell transplant units in South America and Europe.docx by Monica L. Quijano-Lievano (22808537)

    Published 2025
    “…There was a non-significant decrease in clinical deterioration event mortality post-PEWS implementation (24%, n = 17/71 vs. 15%, n = 22/150, p = 0.1335).…”
  17. 15937

    Presentation 1_Baduanjin exercise improves functional capacity and cardiovascular function in older adults with cardiovascular diseases: a systematic review and meta-analysis.pdf by Xingyu Hu (11171774)

    Published 2025
    “…Background<p>Based on clinical observations and expert recommendations, Baduanjin exercise has demonstrated a positive impact on maintaining and enhancing cardiovascular function. …”
  18. 15938

    DataSheet_1_Effectiveness, safety and pharmacokinetics of Polo-like kinase 1 inhibitors in tumor therapy: A systematic review and meta-analysis.docx by Xiao Wei (44054)

    Published 2023
    “…Rigosertib (ON 01910.Na) was associated with a decreased risk of AEs in digestive system (ES, 0.103; 95% CIs, 0.059-0.147), but BI 2536 and Volasertib (BI 6727) increased risk of AEs in blood system (ES, 0.399; 95% CIs, 0.294-0.504). …”
  19. 15939

    DataSheet1_Efficacy and Safety of DL-3-n-Butylphthalide in the Treatment of Poststroke Cognitive Impairment: A Systematic Review and Meta-Analysis.docx by Xueming Fan (11998772)

    Published 2022
    “…</p><p>Result: We identified 26 studies with a total sample size of 2,571 patients. The results of this study showed that NBP as monotherapy or combination therapy had better performance in increasing the MoCA (monotherapy: SMD<sub>N</sub> = 1.05, 95% CI [0.69, 1.42], p < 0.00001; SMD<sub>P</sub> = 1.06, 95% CI [0.59, 1.52], p < 0.00001. combination: SMD<sub>O</sub> = 0.81, 95% CI [0.62, 1.01], p < 0.00001; SMD<sub>N</sub> = 0.90, 95% CI [0.46, 1.33], p < 0.0001; SMD<sub>D</sub> = 1.04, 95% CI [0.71, 1.38], p < 0.00001), MMSE (monotherapy: MD<sub>N</sub> = 4.89, 95% CI [4.14, 5.63]), p < 0.00001). combination: SMD<sub>O</sub> = 1.26, 95% CI [0.97, 1.56], p < 0.00001; SMD<sub>C</sub> = 1.63, 95% CI [1.28, 1.98], p < 0.00001; SMD<sub>N</sub> = 2.13, 95% CI [1.52, 2.75], p < 0.00001) and BI (monotherapy: MD<sub>N</sub> = 13.53, HKSJ 95% CI [9.84, 17.22], p = 0.014. combination: SMD<sub>O</sub> = 2.24, HKSJ 95%CI [0.37, 4.11], p = 0.032; SMD<sub>C</sub> = 3.36, 95%CI [2.80, 3.93], p < 0.00001; SMD<sub>D</sub> = 1.48, 95%CI [1.13, 1.83], p < 0.00001); and decreasing the NIHSS (monotherapy: MD<sub>N</sub> = −3.86, 95% CI [−5.22, −2.50], p < 0.00001. combination: SMD<sub>O</sub> = −1.15, 95% CI [−1.31, −0.98], p < 0.00001; SMD<sub>C</sub> = −1.82, 95% CI [−2.25, −1.40], p < 0.00001) and CSS (combination: MD<sub>O</sub> = −7.11, 95% CI [−8.42, −5.80], p < 0.00001), with no serious adverse reactions observed. …”
  20. 15940

    M-TUBE is a fabrication-free, microfluidics tubing-based bacterial electroporation device that is simple to assemble and exhibits higher electroporation efficiency than cuvettes. by Po-Hsun Huang (183737)

    Published 2022
    “…Transformation was dependent on the electric field. For M-TUBE devices, a voltage of ±2.50 kV (AC field) was applied, which results in an electric field of 8.33 kV/cm. …”